Article Details
Retrieved on: 2022-11-29 23:44:01
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(Nasdaq: VIRI ), a development-stage biotechnology company focused on advancing novel, combination antiviral therapies to treat debilitating chronic ...
Article found on: thefacts.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here